BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 120,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 5th. The shares were sold at an average price of $15.46, for a total transaction of $1,855,200.00. Following the completion of the transaction, the chief executive officer now directly owns […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of BridgeBio Pharma stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total value of $857,475.00. Following the completion of the transaction, the chief financial officer now directly […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of BridgeBio Pharma stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total value of $857,475.00. Following the completion of the transaction, the chief financial officer now owns 101,337 shares […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 120,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 5th. The shares were sold at an average price of $15.46, for a total value of $1,855,200.00. Following the completion of the transaction, the chief executive officer now directly owns […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of the company’s stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total transaction of $857,475.00. Following the completion of the transaction, the chief financial officer now owns […]